RELATING TO RARE DISEASES.
HB 910 establishes or expands Hawaii's rare disease support measures, likely addressing diagnosis access, treatment equity, or patient services through health policy changes.
HB 910 establishes or expands Hawaii's rare disease support measures, likely addressing diagnosis access, treatment equity, or patient services through health policy changes.
HB 910 addresses rare diseases in Hawaii, though the full text is not provided in your summary. Based on the committee referrals (Health, Education, Consumer Protection, and Finance), the bill likely proposes measures related to rare disease diagnosis, treatment access, patient support, or healthcare provider education. The bill was introduced in January 2025 and carried over to the 2026 session, indicating it did not advance to passage in the initial legislative period.
Rare diseases affect a small percentage of the population but collectively impact thousands of Hawaii residents who face significant challenges accessing diagnosis, treatment, and support services. These conditions are often under-researched and under-resourced, making state-level policy intervention necessary to improve patient outcomes and healthcare system preparedness.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.